KRYSTALYN WILLIAMS: Open Payments
NPI 1811740327 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 88 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,036 · 2025 $1,910
Food & beverage: $1,755Education: $155
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $523 |
| Novartis Pharmaceuticals Corporation | 11 | $311 |
| Travere Therapeutics, Inc. | 10 | $262 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $239 |
| OPKO Pharmaceuticals, LLC | 12 | $155 |
| Calliditas Therapeutics US Inc. | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 6 | $92 |
| Ardelyx, Inc. | 3 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
Products named: KRYSTEXXA, Kerendia, RAYALDEE, TARPEYO, IBSRELA, FARXIGA, JARDIANCE, Filspari.
Industry payments across AR — which companies pay providers there.
